# Genesis MedTech starts Phase II expansion in Wuxi for antibacterial sutures

Genesis MedTech (Jianshi Medical) began construction of its Phase II project in Wuxi, China, with an investment of nearly CNY 1 billion, to produce antibacterial sutures by December 2024.

- Type: Expansion
- Announced: 2024-05-23
- Where: Wuxi, Jiangsu, China, China
- Value: $138.0M (1.00B CNY)
- Starts operating: Dec 2024
- Status: under construction
- Products: antibacterial sutures, triclosan-coated antibacterial sutures
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Genesis MedTech (Jianshi Medical Technology Group)](https://endata.com/companies/77604.md)

## Sources

- [wxrb.com](https://www.wxrb.com/doc/2024/05/23/348311.shtml), 2024-05-23: "健适医疗无锡二期项目正式开工，项目年底投产后，健适将在无锡实现抗菌缝线的规模化生产。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.